Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib

被引:3
|
作者
Taguchi, Takahide [1 ]
Tsukuda, Mamoru [1 ,2 ]
Imagawa-Ishiguro, Yukari [2 ]
Kato, Yasumasa [3 ]
Sano, Daisuke [2 ]
机构
[1] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Biol & Funct Head & Neck, Yokohama, Kanagawa 2360004, Japan
[3] Kanagawa Dent Coll, Dept Biochem & Mol Biol, Yokosuka, Kanagawa 2388580, Japan
关键词
epidermal growth factor receptor; head and neck cancer; gene mutation; sensitivity to gefitinib;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidermal growth factor receptor (EGFR) gene mutations are associated with the sensitivity of non-small cell lung carcinomas (NSCLCs) to gefitinib, but such findings have not been reported in squamous cell carcinomas of the head and heck (SCCHNs). Accordingly, we determined whether EGFR gene expression and mutations correlate with the in vitro efficacy of gefitinib in SCCHN cell lines. EGFR status was analyzed in 16 different SCCHN cell lines by polymerase chain reaction (PCR) and direct sequencing for activating mutations, by real-time quantitative RT-PCR, and by Western blot analysis for RNA and protein expression. Using direct sequencing of PCR products from exons 18-23 of 9 SCCHN cell lines, we found a heterozygous EGFR mutation (EGFR(mut)) with a 2607G A transition in exon 20 (G/A genotype). The 9 different cell lines that showed this mutation also showed higher sensitivity (lower IC50 values) to gefitinib than cell lines with wild-type EGFR (EGFR(wt): G/G genotype) (p=0.016). EGFR protein levels correlated robustly (r=0.76) and significantly (p=0.0007) with EGFR mRNA levels and with IC50 values for gefitinib (r=0.65, p=0.0067). EGFR mRNA correlated with IC50 values (r=0.67, p=0.0046). Our conclusion was that the heterozygous and synonymous transition of the EGFR gene and low EGFR expression levels of mRNA and protein in SCCHN may be reliable predictors of high sensitivity in SCCHN patients to gefitinib.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 50 条
  • [1] Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines
    Wagenblast, Jens
    Hambek, Markus
    Baghi, Mehran
    Knecht, Rainald
    ANTICANCER RESEARCH, 2008, 28 (2A) : 687 - 692
  • [2] Analysis of the EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma before Treatment with Gefitinib
    Bontognali, Sven
    Pless, Miklos
    Brutsche, Martin H.
    Fischer, Claude
    Rochlitz, Christoph
    Buess, Martin
    ONKOLOGIE, 2013, 36 (04): : 161 - +
  • [3] EGFR Mutations in Head and Neck Squamous Cell Carcinoma
    Nair, Sindhu
    Bonner, James A.
    Bredel, Markus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [4] Head and neck squamous carcinoma cell lines exhibit an intact EGFR signaling pathway and variable response to EGFR agonist and antagonist
    Wong, S.
    Springer, J.
    Fox, D.
    Venkatesan, N.
    Head, C.
    EJC SUPPLEMENTS, 2006, 4 (12): : 182 - 182
  • [5] Gefitinib effectiveness in an head and neck squamous cell carcinoma in vitro model
    Sebastian, Sinto
    Azzariti, Amalia
    Porcelli, Letizia
    Simone, Grazia M.
    Tommasino, Massimo
    Paradiso, Angelo
    CANCER RESEARCH, 2006, 66 (08)
  • [6] EGFR Inhibitors for the Treatment of Squamous Cell Carcinoma of the Head and Neck
    Mehra, Ranee
    Cohen, Roger B.
    Harari, Paul M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (02) : 176 - 184
  • [7] EGFR inhibition as a therapy for head and neck squamous cell carcinoma
    Loeffler-Ragg, Judith
    Schwentner, Ilona
    Sprinzl, Georg M.
    Zwierzina, Heinz
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (10) : 1517 - 1531
  • [8] EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
    Ranee Mehra
    Roger B. Cohen
    Paul M. Harari
    Current Oncology Reports, 2008, 10 : 176 - 184
  • [9] Proteomic profiling of head and neck squamous cell carcinoma cell lines
    Sepiashvili, Lusia
    Hui, Angela
    Ignatchenko, Vladimir
    Waldron, Levi
    Jurisica, Igor
    Kislinger, Thomas
    Liu, Fei-Fei
    CANCER RESEARCH, 2011, 71
  • [10] Thermoradiotherapy in human head and neck squamous cell carcinoma cell lines
    Asaumi, JI
    Higuchi, Y
    Murakami, J
    Kuroda, M
    Shibuya, K
    Konouchi, H
    Hisatomi, M
    Matsuzaki, H
    Shigehara, H
    Kawasaki, S
    Kishi, K
    Hiraki, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2002, 10 (03) : 287 - 291